InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Frazier Kenneth C, Autre. Director active across 3 companies, notably Merck & Co., Inc.. Cumulatively, 9 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €1.7m. Activity tracked since 9 November 2021. The latest transaction was filed on 4 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Frazier Kenneth C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
111,111 股@ US$18.00100.0% 占其流量Common StockSEC:0001193125-26-041555:0
标准退出：2026年5月5日 (T+90)
235,769 股0Common StockSEC:0001127602-22-025118:0
235,000 股0Common StockSEC:0001127602-22-025018:0
300,000 股0Common StockSEC:0001127602-22-024871:0
567,084 股0Common StockSEC:0001127602-22-024610:0
119,488 股@ US$73.51100.0% 占其流量Common StockSEC:0001127602-22-007005:0
2,500 股0Common StockSEC:0001127602-22-000634:0
663,881 股0Common StockSEC:0001127602-21-028802:0
2,500 股Common StockSEC:0001127602-16-036237:0
9 条申报中的 9 条
About Frazier Kenneth C
FRAZIER KENNETH C is a declarant linked to Merck & Co., Inc., Exxon Mobil CORP, and Eikon Therapeutics, Inc., with the stated roles of Executive Chair at Merck & Co., Inc. and Director at Exxon Mobil CORP and Eikon Therapeutics, Inc. He has 9 filings in total, and across the 9 sampled recent filings, buy volume is EUR 1692598 and sell volume is EUR 0, with a date range from 2016-01-06 to 2026-02-06; the most common transaction nature is Option exercise.
